TY  - GEN
N2  - Based on a review of recent literature, this WIPO Global Challenges Report includes a broad overview of current approaches and consortia designed to meet the challenge of research and development (R&D) investment for new treatments. It also examines patent applications by both the public and the private sectors as an indicator of innovative activity.
DO  - 10.34667/tind.29008
DO  - doi
AB  - Based on a review of recent literature, this WIPO Global Challenges Report includes a broad overview of current approaches and consortia designed to meet the challenge of research and development (R&D) investment for new treatments. It also examines patent applications by both the public and the private sectors as an indicator of innovative activity.
T1  - Antimicrobial Resistance (AMR) and Multidrug Resistance (MDR) :Overview of current approaches, consortia and intellectual property issues.
AU  - Bhagwandin, Niresh.
L1  - https://tind.wipo.int/record/29008/files/wipo_pub_gc_15.pdf
LA  - eng
ID  - 29008
L4  - https://tind.wipo.int/record/29008/files/wipo_pub_gc_15.pdf
KW  - Intellectual property.
KW  - Patents.
TI  - Antimicrobial Resistance (AMR) and Multidrug Resistance (MDR) :Overview of current approaches, consortia and intellectual property issues.
L2  - https://tind.wipo.int/record/29008/files/wipo_pub_gc_15.pdf
LK  - https://tind.wipo.int/record/29008/files/wipo_pub_gc_15.pdf
UR  - https://tind.wipo.int/record/29008/files/wipo_pub_gc_15.pdf
ER  -